deeptech Value proposition
GlycoBAR: a new and cost effective way to get rid for blood group antibodies. No blood group barrier any more !
GlycoBAR sells blood group antigen ligands that can be used to make plasma "Universal" (=compatible with all recipients, whichever the blood group of the donor is). Our ligands are also allowing transplant of organs when donor and recipients are belonging to incompatible blood group
Biofermentation, Blood purification, Blood group antibody removal, and Isoagglutinins removalOriginal language
GlycoBAR: a new and cost effective way to get rid for blood group antibodies. No blood group barrier any more !
GlycoBAR sells blood group antigen ligands that can be used to make plasma "Universal" (=compatible with all recipients, whichever the blood group of the donor is). Our ligands are also allowing transplant of organs when donor and recipients are belonging to incompatible blood group
GlycoBAR – Improving safety of blood derivative products
http://glycobar.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | SAVOIE-ANGELS - Investissement de proximité | Other 29 Oct 2023 | | |
 MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 30 Jun 2024 | | |
 Auvergne-Rhône-Alpes Entreprises National and local authorities, Business Consulting and Services | Auvergne-Rhône-Alpes Entreprises National and local authorities, Business Consulting and Services | Other 13 Feb 2024 | | |
 Grenoble Angels - Oser l'entreprise Startup accelerator & VC | Grenoble Angels - Oser l'entreprise Startup accelerator & VC | Other 19 Mar 2024 | | |